These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 8018559

  • 1. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S, Huang F, Hafez M, Winawer S, Friedman E.
    Cell Growth Differ; 1994 Mar; 5(3):267-75. PubMed ID: 8018559
    [Abstract] [Full Text] [Related]

  • 2. Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.
    Hafez MM, Infante D, Winawer S, Friedman E.
    Cell Growth Differ; 1990 Dec; 1(12):617-26. PubMed ID: 2288877
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 7. Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect.
    Hsu S, Huang F, Friedman E.
    J Cell Physiol; 1995 Nov 15; 165(2):239-45. PubMed ID: 7593201
    [Abstract] [Full Text] [Related]

  • 8. Repression of autocrine transforming growth factor beta 1 and beta 2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties.
    Wu SP, Sun LZ, Willson JK, Humphrey L, Kerbel R, Brattain MG.
    Cell Growth Differ; 1993 Feb 15; 4(2):115-23. PubMed ID: 8494782
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Two roles for transforming growth factor beta 1 in colon enterocytic cell differentiation.
    Hafez MM, Hsu S, Yan Z, Winawer S, Friedman E.
    Cell Growth Differ; 1992 Nov 15; 3(11):753-62. PubMed ID: 1334691
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Up-regulation of transforming growth factor alpha expression by transforming growth factor beta 1, epidermal growth factor, and N,N-dimethylformamide in human colon carcinoma cells.
    Zipfel PA, Ziober BL, Morris SL, Mulder KM.
    Cell Growth Differ; 1993 Aug 15; 4(8):637-45. PubMed ID: 8398905
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role for transforming growth factor-beta (TGF-beta) in human cancer.
    Gold LI.
    Crit Rev Oncog; 1999 Aug 15; 10(4):303-60. PubMed ID: 10654929
    [Abstract] [Full Text] [Related]

  • 19. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line.
    Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T.
    Br J Cancer; 1999 Aug 15; 80(11):1708-17. PubMed ID: 10468286
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.